Prognosis in cutaneous T-cell lymphoma by skin stage: long-term survival in 489 patients.
about
Interventions for mycosis fungoidesInterventions for mycosis fungoidesDenileukin diftitox for the treatment of cutaneous T-cell lymphomaExpression of cancer/testis antigens in cutaneous T cell lymphomas.Phase II multi-institutional trial of the histone deacetylase inhibitor romidepsin as monotherapy for patients with cutaneous T-cell lymphomaThe current management of mycosis fungoides and Sézary syndrome and the role of radiotherapy: Principles and indicationsSilicon phthalocyanine (Pc 4) photodynamic therapy is a safe modality for cutaneous neoplasms: results of a phase 1 clinical trialThe influence of the coexpression of CD4 and CD8 in cutaneous lesions on prognosis of mycosis fungoides: a preliminary study.Romidepsin (Istodax, NSC 630176, FR901228, FK228, depsipeptide): a natural product recently approved for cutaneous T-cell lymphomaInterleukin-13 is overexpressed in cutaneous T-cell lymphoma cells and regulates their proliferation.Romidepsin in the treatment of cutaneous T-cell lymphoma.Overview of cutaneous T-cell lymphoma: prognostic factors and novel therapeutic approaches.Lesional gene expression profiling in cutaneous T-cell lymphoma reveals natural clusters associated with disease outcomeMycosis fungoides: A case reportTreatment of cutaneous T-cell lymphoma with retinoids.The diagnosis, staging, and treatment options for mycosis fungoides.Mycosis fungoides and Sezary syndrome against a human immunodeficiency virus-positive background: case report.Mycosis fungoides with large cell transformation: clinicopathological features and prognostic factors.Long-term outcomes of 1,263 patients with mycosis fungoides and Sézary syndrome from 1982 to 2009.Cutaneous T-cell lymphoma in sub-Saharan Africa.Review of the treatment of mycosis fungoides and Sézary syndrome: A stage-based approach.Emerging role of the histone deacetylase inhibitor romidepsin in hematologic malignancies.Myxoid variant of anaplastic large cell lymphoma involving the skin: a case report.Prognostic factors, prognostic indices and staging in mycosis fungoides and Sézary syndrome: where are we now?Racial differences in the use of extracorporeal photopheresis for mycosis fungoides.Brentuximab vedotin in CD30(+) primary cutaneous T-cell lymphomas: a review and analysis of existing data.Evaluation of neutrophil-lymphocyte ratio in patients with early-stage mycosis fungoides.Early changes in miRNA expression are predictive of response to extracorporeal photopheresis in cutaneous T-cell lymphoma.Second Primary Malignancies in CTCL Patients from 1992 to 2011: A SEER-Based, Population-Based Study Evaluating Time from CTCL Diagnosis, Age, Sex, Stage, and CD30+ Subtype.Bexarotene capsules and gel for previously treated patients with cutaneous T-cell lymphoma: results of the Australian patients treated on phase II trials.Treatment of cutaneous T-cell lymphoma with alitretinoin gel.Topical imiquimod therapy for cutaneous T-cell lymphoma.Bexarotene--an alternative therapy for progressive cutaneous T-cell lymphoma? First experiences.Time course, clinical pathways, and long-term hazards risk trends of disease progression in patients with classic mycosis fungoides: a multicenter, retrospective follow-up study from the Italian Group of Cutaneous Lymphomas.Early-stage mycosis fungoides screening investigations: a retrospective analysis of 440 cases.CD45RA+ immunophenotype in mycosis fungoides: clinical, histological and immunophenotypical features in 22 patients.Histologic criteria for the diagnosis of mycosis fungoides: proposal for a grading system to standardize pathology reporting.Prognostic indicators for mycosis fungoides in a Greek population.18F-fluorodeoxyglucose-positron emission tomography in evaluation of primary cutaneous lymphoma.Neoplasms
P2860
Q24200749-1E4A8F26-BF07-4B43-BC5A-F254714D8085Q24235242-0774AEFB-32CE-4831-AA32-73E934C0940AQ24650893-E56111F7-2D31-41F1-9147-0C24D1982ECEQ31036179-2B95563B-9BF9-4EB1-97B2-3C7873998E3DQ33386623-DC9349A4-E464-4490-A21D-A71488683D69Q33746059-41C80204-4D47-4465-8903-C519F6A0B0E9Q33796958-085E2B0C-A7A8-413E-92A1-F744959A00A0Q34037897-A2EF86C4-CB04-47A4-AA66-65F02AD078FEQ35186682-D9F367C4-BA6B-4759-888D-A385AC35E526Q35584244-FAEA427D-8E99-4862-8DF4-DABC4EEBFF18Q35683831-4C2EAD86-7BE1-480D-9FB1-D61E6C60C176Q35808399-8EB461BA-B9CC-4560-BE60-9C4C1D68A1C1Q36059635-226C16E9-79D0-45F9-9AD9-9DAF87FC05DCQ36262715-4C22CAC6-5C48-4570-A5A1-780F0BB48139Q36609811-5EE58163-2B28-46B6-B5F1-E489243656D0Q36771218-8E65D7ED-99E9-43E5-BB48-767EA32A5F73Q36962214-1CAC8663-A946-47D8-8EF5-55AA08FF0A68Q37296614-3A80129D-BBCC-4ADD-AB51-621C87D84138Q37379370-9080833E-12B6-4E64-9153-5DF0E08D1907Q37398969-488B293D-E3BB-4FC1-BA07-09E218F43172Q37444717-F80F1CDC-064C-454C-BBC3-2AA45572B1FAQ37809875-BE2D6FE7-2B70-4CC1-8AA8-79A66C9ABBC3Q38011745-854C1BF9-AC41-43D0-935E-A77F0845E9B6Q38196931-74E22A10-5598-4494-82B7-C17F0B6227F2Q38230665-A8DA2B35-9D03-4BE9-A852-DC2495EF4078Q38649847-46BC14B9-3DFD-4FC1-805D-9A5E5A3F3F3BQ39503272-07E8374A-202D-435D-991B-4143EAEC554DQ40173571-368E4BEC-4DE5-43B4-9BAA-FEF2A190B79AQ41342946-46259769-303B-4411-BCC1-C27CC628C8F6Q43579501-1DEA4232-6CE1-48AA-9D91-43D871C9A8BAQ43975407-620E19C1-4079-4796-BB93-976C93345D2CQ44691746-1DAAA9FC-3114-4C98-BD21-431AFFD1E538Q46799392-28C9B282-68C7-4C65-9733-BAC54F5E9225Q47654977-41272280-B718-4307-8FCC-DE2F6B5CD130Q50002389-36111321-5387-4727-A68A-8961368CA1CBQ52018886-1B22B1ED-21FD-4990-8B55-4A427E8AFCF2Q52932626-289DE431-5BB3-4C0D-BBA6-8ED1AC17A21CQ53039521-ED3AE360-CB7C-4F3C-BC79-A3E0A40440A0Q53526491-920A376E-D986-4B56-94BA-1A05F9158B8FQ56828372-72B6081C-1F2C-469F-9160-242AE042C9AE
P2860
Prognosis in cutaneous T-cell lymphoma by skin stage: long-term survival in 489 patients.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Prognosis in cutaneous T-cell lymphoma by skin stage: long-term survival in 489 patients.
@en
type
label
Prognosis in cutaneous T-cell lymphoma by skin stage: long-term survival in 489 patients.
@en
prefLabel
Prognosis in cutaneous T-cell lymphoma by skin stage: long-term survival in 489 patients.
@en
P2093
P1476
Prognosis in cutaneous T-cell lymphoma by skin stage: long-term survival in 489 patients.
@en
P2093
Kashani-Sabet M
McMillan A
Zackheim HS
P304
P356
10.1016/S0190-9622(99)70491-3
P407
P577
1999-03-01T00:00:00Z